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Background: Although Chlamydia trachomatis-induced Reac-
tive Arthritis (ReA) constitutes a signiﬁcant disease burden in
various countries, however it remains largely unrecognized and
probably underestimated in India. Due to availability of multiple
serovars, biphasic lifecycle and asymptomatic infection, diagnosis
of this pathogen is difﬁcult, thereby leading to chronic, persis-
tent chlamydial infection in the synovium. The aim of the present
prospective study was to ﬁnd the presence of intra-articular C.
trachomatis infection by nucleic acid ampliﬁcation tests and secre-
tory IgA determination in patients with ReA and in forme fruste of
ReA, viz.: Undifferentiated Spondyloarthropathy (uSpA) attending
a major tertiary Army hospital inNew Delhi (India).
Methods & Materials: Synovial ﬂuid was aspirated from the
knee joints of age and sex-matched 30 arthritic patients, viz.:
ReA/uSpA (n=15) and Osteoarthritis controls (OA) (n =15) fol-
lowing the European Spondyloarthropathy Study Group criteria
for ReA while clinical and radiological diagnosis was done for
OA patients. The clinical details were recorded in all patients.
Both C. trachomatis-speciﬁc surface Major Outer Membrane Pro-
tein (MOMP) and endogenous plasmid genes were targeted using
semi-nested Polymerase Chain Reaction (snPCR) and nested PCR
(nPCR), while anti-C. trachomatis IgA antibodies were estimated
by commercial enzyme-linked immunosorbent assay kit (Savyon
Diagnostics, Israel). Statistical evaluation of data was done by using
trial version of Graph Prism Pad software (version 5.0; GraphPad
Software, Inc., San Diego, California, USA).
Results: Overall, 33.3% (5/15) ReA/uSpA patients were found
to be C. trachomatis-positive for either MOMP/plasmid gene in
the joint ﬂuid. 20% (3/15) were positive for plasmid gene while
MOMPgenewas present in 13.3% (2/15) patients in the study group
(ReA/uSpA). Intra-articular anti-C. trachomatis IgA antibodies were
detected in 26.6% (4/15) patients in the synovial ﬂuid. Signiﬁcant
correlation (‘p’ value <0.05) was found between PCR and serologic
ﬁndings. None of OA controls was found positive for either chla-
mydial antibody/MOMP gene/plasmid gene.
Conclusion: The observations in the present study indicate that
intra-articular C. trachomatis infection in ReA/uSpA patients is both
underestimated as well as underdiagnosed inIndia. It also suggests
the usefulness of serology for better clinical management of such
patients.
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Relative prevalence of STI pathogens, vaginal
conditions and HIV co-infection among STI
patients attending Alexandra Health Centre,
Gauteng Province, South Africa (2011-2013)
N.B. Sewpershad ∗, I. Venter, L. Gumede, V.
Kekane, G. de Gita, V. Maseko, D. Lewis
Centre for HIV and STIs, Johannesburg, South Africa
Background: To determine the aetiology of urethral discharge
(MUS), vaginal discharge (VDS) and genital ulcer (GUS) syndromes
as well as the prevalence of HIV co-infections in Gauteng between
January and April 2011-2013.
Methods & Materials: A total of 1180 consecutive patients
were recruited at Alexandra Health Clinic, Johannesburg. From
this total, 402 presented with MUS, 620 presented with VDS and
203 presented with GUS including mixed syndromes. Urethral
swabs/smears (MUS), endocervical swabs/vaginal smears (VDS),
genital ulcer swabs/smears (GUS) and sera (all) were collected
with written informed consent. A real-time multiplex PCR assay
was used to detect Neisseria gonorrhoeae (NG), Chlamydia tracho-
matis (CT), Trichomonas vaginalis (TV) and Mycoplasma genitalium
(MG) from MUS/VDS swabs, and herpes simplex virus (HSV), Tre-
ponema pallidum (TP) Haemophilus ducreyi (HD) and C. trachomatis
L1-3 (LGV) from ulcer swabs. Vaginal smears (VDS) were examined
for bacterial vaginosis (BV) and candidiasis (CA) and genital ulcer
smears (GUS) for granuloma inguinale (GI). Sera were tested for
HIV.
Results: N. gonorrhoeae was the most common aetiological
agent (309/402; 76.9%) for MUS cases; BV the most common
non-STI cause of VDS (346/620; 55.8%) and HSV accounted for
the majority of ulcers (127/203; 62.6%). Chlamydia trachomatis
accounted for 27.6% (111/402)MUSand16.6% (103/620) VDS cases,
Mycoplasma genitalium accounted for 8.2% (33/402) MUS and 9.7%
(60/620) VDS cases whereas Trichomonas vaginalis accounted for
4.2% (17/402) and 22.9% (142/620) of MUS and VDS cases respec-
tively. T. pallidum accounted for 1.5% (3/203) of GUS cases. There
was only 1 case of LGV. There were no cases of H. ducreyi and GI.
The seroprevalence of HIV was 31.0% (130/402) among MUS, 45.2%
(280/620) among VDS and 57.1% (116/203) among GUS patients.
Conclusion: Gonorrhoea, BV and HSV are the leading causes of
MUS, VDS and GUS respectively. The HIV co-infection data empha-
size the importance of STI patients as a focus forHIVHCT initiatives.
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